<DOC>
	<DOCNO>NCT00835978</DOCNO>
	<brief_summary>Axitinib dose titration ( give high dose drug standard start dose ) among certain patient may improve response treatment .</brief_summary>
	<brief_title>Axitinib ( AG-013736 ) With Or Without Dose Titration ( Increase ) In Patients With Kidney Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Axitinib</mesh_term>
	<criteria>metastatic renal cell carcinoma ( kidney cancer ) clear cell component prior systemic therapy ( include prior adjuvant neoadjuvant ) Eastern Cooperative Oncology Group ( ECOG ) Performance Status 01 Blood Pressure &lt; = 140/90mmHg brain/CNS metastasis use 2 blood pressure medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>axitinib AG-013736 dose titration ( increase ) renal cell carcinoma</keyword>
	<keyword>kidney cancer</keyword>
</DOC>